2nd Circ. Quashes Savient Investor’s Class Action – site.law360.com

Law360, New York (January 17, 2012, 9:15 PM ET) -- The Second Circuit on Friday backed the dismissal of a putative securities fraud class action accusing Savient Pharmaceuticals Inc. of misleading investors by holding back reports of adverse reactions to ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>